Supplementary Figure 1 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC

Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma, Ryota Saito, Hiroaki Akamatsu, Kimio Yonesaka, Mikiko Kakegawa, Hiromi Nagashima, Satoshi Takahashi, Masaki Fujita, Noriko Yanagitani, Kiichiro Ninomiya, Yasuhiko Nishioka, Keita Mori, Shigehisa Kitano, Koji Tamada, Nobuyuki Yamamoto, Akihiko Gemma, Tetsuya Mitsudomi